We are live on
!
Find out more
B
Bailard Portfolio holdings
AUM
$4.35B
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$640M
AUM Growth
-$7.12M
(-1.1%)
Cap. Flow
+$22.6M
Cap. Flow
% of AUM
3.54%
Top 10 Holdings %
Top 10 Hldgs %
53.7%
Holding
293
New
53
Increased
89
Reduced
80
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$59.2M |
| 2 |
Vanguard Total Bond Market
BND
|
+$59.1M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$19.5M |
| 4 |
iShares California Muni Bond ETF
CMF
|
+$5.19M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$58.6M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$58.1M |
| 3 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$3.59M |
| 4 |
Ryanair
RYAAY
|
+$3.57M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$3.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.58% |
| 2 | Technology | 6.37% |
| 3 | Industrials | 3.53% |
| 4 | Financials | 2.65% |
| 5 | Real Estate | 2.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Arbutus Biopharma
ABUS
$855M
| $1.31M | 0.2% |
215,000
+76,000
| +55% | +$674K |
|
77
iShares Expanded Tech Sector ETF
IGM
$10.3B
| $1.3M | 0.2% |
78,090
+1,320
| +2% | +$22.9K |
|
78
Ocular Therapeutix
OCUL
$1.88B
| $1.29M | 0.2% |
92,000
+37,000
| +67% | +$743K |
|
79
ICICI Bank
IBN
$106B
| $1.28M | 0.2% |
165,220
-16,280
| -9% | -$139K |
|
80
iShares US Real Estate ETF
IYR
$4.5B
| $1.28M | 0.2% |
18,010
-4,705
| -21% | -$343K |
|
|
DISH
81
DELISTED
DISH Network Corp.
DISH
| $1.24M | 0.19% |
21,325
-625
| -3% | -$39.6K |
|
82
State Street Technology Select Sector SPDR ETF
XLK
$117B
| $1.24M | 0.19% |
62,666
+17,286
| +38% | +$356K |
|
83
Dr. Reddy's Laboratories
RDY
$9.48B
| $1.23M | 0.19% |
95,150
+45,150
| +90% | +$561K |
|
|
DFS
84
DELISTED
Discover Financial Services
DFS
| $1.21M | 0.19% |
23,324
-1,483
| -6% | -$81.3K |
|
85
Humana
HUM
$47.7B
| $1.21M | 0.19% |
6,778
-125
| -2% | -$23.1K |
|
86
PPG Industries
PPG
$26.2B
| $1.19M | 0.19% |
13,606
-63
| -0.5% | -$6.41K |
|
87
Accenture
ACN
$85.7B
| $1.19M | 0.19% |
12,107
-338
| -3% | -$33.5K |
|
88
UnitedHealth
UNH
$392B
| $1.19M | 0.19% |
10,235
-445
| -4% | -$53.3K |
|
89
Vanguard Communication Services ETF
VOX
$5.7B
| $1.18M | 0.18% |
15,010
+200
| +1% | +$16.9K |
|
90
Bristol-Myers Squibb
BMY
$124B
| $1.16M | 0.18% |
19,569
-1,575
| -7% | -$99.9K |
|
91
General Dynamics
GD
$101B
| $1.15M | 0.18% |
8,325
-1,468
| -15% | -$212K |
|
92
Camden Property Trust
CPT
$11.1B
| $1.12M | 0.17% |
+15,100
| New | +$1.14M |
|
93
COPT Defense Properties
CDP
$4.23B
| $1.07M | 0.17% |
51,100
+14,000
| +38% | +$316K |
|
|
ARRY
94
DELISTED
Array Biopharma Inc
ARRY
| $1.03M | 0.16% |
225,000
| – | – |
|
|
AGEN
95
Agenus
AGEN
$230M
| $980K | 0.15% |
10,852
+1,222
| +13% | +$181K |
|
96
Chunghwa Telecom
CHT
$33.2B
| $976K | 0.15% |
32,060
+22,060
| +221% | +$674K |
|
97
EastGroup Properties
EGP
$11.6B
| $975K | 0.15% |
+18,000
| New | +$1.02M |
|
98
American Tower
AMT
$77.4B
| $968K | 0.15% |
+11,000
| New | +$1.04M |
|
99
Fidelity MSCI Energy Index ETF
FENY
$2.01B
| $967K | 0.15% |
55,620
-31,420
| -36% | -$602K |
|
|
IMUC
100
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
| $945K | 0.15% |
56,250
+23,921
| +74% | +$435K |
|
Similar funds
EC
SFM
NHC
EQF
CCM
NEI
Bailard's Q3 2015 Portfolio in Review
As of Q3 2015, Bailard held 293 positions worth $640M, down 1.1% from $647M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Bailard deployed $22.6M of net new capital in Q3 2015, opening 53 new positions and adding to 89 existing holdings. Its largest new stake was Vanguard Total Bond Market: 725,301 shares worth $59.4M.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 8.1% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $58.6M trimmed.
- Bailard's largest Q3 2015 buy was Vanguard Total Bond Market: 725,301 shares worth $59.4M.
- Bailard added most to iShares 20+ Year Treasury Bond ETF in Q3 2015, an estimated $59.2M increase.
- Bailard's biggest Q3 2015 reduction was Invesco QQQ Trust, cutting an estimated $58.6M.
- Bailard fully exited Spark Therapeutics, Inc. Common Stock in Q3 2015, selling an estimated $3.59M.
- Bailard's ten largest holdings make up 54% of its $640M portfolio in Q3 2015.
- Bailard opened 53 new positions and closed 47 in Q3 2015.
- Bailard's portfolio value fell 1.1% quarter-over-quarter to $640M.
Based on Bailard's 13F filing for Q3 2015, filed 13 Nov 2015.